Replimune Group, Inc.

NASDAQ:REPL

Biotechnology

Healthcare
$19.81 +1.85%

+$0.19 today

Market cap
$1.88B
Beta
0.91
P/E (TTM)
-3.0
EPS (TTM)
-$3.42
52W Low $1.50High $13.24

Volume 2.13M

Average 7.51M

Price history

Replimune Group, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+120.36%

Period high

$23.28

Period low

$1.70

Latest

$19.81

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GNov 10, 2026Nov 10, 2026
4Nov 10, 2026Nov 10, 2026
SC 13G/ANov 9, 2026Nov 9, 2026
10-Q/ANov 6, 2026Nov 6, 2026
4Nov 3, 2026Nov 3, 2026
8-KOct 28, 2026Oct 28, 2026
10-QOct 28, 2026Oct 28, 2026
8-KSep 16, 2026Sep 16, 2026
4Aug 24, 2026Aug 24, 2026
4Aug 19, 2026Aug 19, 2026
8-KAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
S-3ASRAug 14, 2026Aug 14, 2026
10-QAug 14, 2026Aug 14, 2026
4Aug 12, 2026Aug 12, 2026

Competitors

Who does Replimune Group, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about REPL's filings, answered from its disclosures.

What is the latest REPL filing?

The latest filing shown is SC 13G dated Nov 10, 2026.

How many recent filings does REPL have?

Intrinsic Alpha currently shows 20 recent filings for REPL.